Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	The Angels Initiative Stroke prevention

Autoimmune Disorders

Free Subscription 22.05.2023 2 Ann Neurol 2 BMC Neurol 8 Diabet Med 5 Diabetes Res Clin Pract 7 Intern Med 2 J Autoimmun 3 J Clin Endocrinol Metab 4 J Immunol 3 J Neuroimmunol 7 J Neurol 4 Mult Scler 1 Neurologia (Engl Ed) 1 Neurology 2 PLoS One

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Ann Neurol

1. HOLM HANSEN R, von Essen MR, Mahler MR, Cobanovic S, et al
   Cladribine effects on T and B cells and T cell reactivity in multiple sclerosis.
   Ann Neurol. 2023 May 16. doi: 10.1002/ana.26684.
   PubMed         Abstract available
   
   
2. PATRICK MT, Nair RP, He K, Stuart PE, et al
   Shared Genetic Risk Factors for Multiple Sclerosis/Psoriasis Suggest Involvement of Interleukin-17 and Janus Kinase-Signal Transducers and Activators of Transcription Signaling.
   Ann Neurol. 2023 May 1. doi: 10.1002/ana.26672.
   PubMed         Abstract available
   
   

   
   BMC Neurol

3. LI Y, Tang M, Yu L, He Y, et al
   Anti-ganglioside antibody positive neuromyelitis optica spectrum disorders with peripheral neuropathy: a case report.
   BMC Neurol. 2023;23:189.
   PubMed         Abstract available
   
   
4. SHEN F, Hu LH, Huang HS, Li L, et al
   Development and validation of the scale for symptom clusters in patients with myasthenia gravis.
   BMC Neurol. 2023;23:196.
   PubMed         Abstract available
   
   

   
   Diabet Med

5. RYTTER K, Madsen KP, Andersen HU, Hommel E, et al
   Associations between insulin pump self-management and HbA1c in type 1 diabetes.
   Diabet Med. 2023 Feb 14:e15068. doi: 10.1111/dme.15068.
   PubMed         Abstract available
   
   
6. SHAH N, Deshmukh H, Wilmot EG, Patmore J, et al
   The long-term impact of glucose monitoring with the FreeStyle Libre on glycaemic control and hypoglycaemia awareness in people with insulin-dependent diabetes mellitus: Insights from the Association of British Clinical Diabetologists national audit.
   Diabet Med. 2023 Feb 16:e15070. doi: 10.1111/dme.15070.
   PubMed         Abstract available
   
   
7. STUCKEY HL, Desai U, Mitchell BD, Pearson TL, et al
   "Didn't See the Need": Misperceptions about glucagon from the perspectives of people with diabetes and their caregivers.
   Diabet Med. 2023 Mar 16:e15084. doi: 10.1111/dme.15084.
   PubMed         Abstract available
   
   
8. WANG XS, Dunlop AD, McKeen JA, Feig DS, et al
   Real-world use of Control-IQ technology automated insulin delivery in pregnancy: A case series with qualitative interviews.
   Diabet Med. 2023;40:e15086.
   PubMed         Abstract available
   
   
9. BERNABE-ORTIZ A, Carrillo-Larco RM, Safary E, Vetter B, et al
   Use of continuous glucose monitors in low- and middle-income countries: A scoping review.
   Diabet Med. 2023;40:e15089.
   PubMed         Abstract available
   
   
10. BOUGHTON CK, Hartnell S, Hobday N, Lake A, et al
    Implementation of fully closed-loop insulin delivery for inpatients with diabetes: real-world outcomes.
    Diabet Med. 2023 Mar 22:e15092. doi: 10.1111/dme.15092.
    PubMed         Abstract available
    
    
11. ACCIAROLI G, Parkin CG, Thomas R, Layne J, et al
    G6 continuous glucose monitoring system feature use and its associations with glycaemia in Europe.
    Diabet Med. 2023;40:e15093.
    PubMed         Abstract available
    
    
12. MACKIE T, Morrow TD, Abadula FJ, Jaser SS, et al
    Importance of Caregivers' Subjective Social Status and Neighbourhood Disadvantage for Adolescents with Type 1 Diabetes.
    Diabet Med. 2023 Mar 30:e15097. doi: 10.1111/dme.15097.
    PubMed         Abstract available
    
    

    
    Diabetes Res Clin Pract

13. ALBALADEJO L, Perinet-Marquet P, Buis C, Lablanche S, et al
    High prevalence with no gender difference of likely eating disorders in type 1 mellitus diabetes on insulin pump.
    Diabetes Res Clin Pract. 2023;199:110630.
    PubMed         Abstract available
    
    
14. NATTERO-CHAVEZ L, Lecumberri Pascual E, De La Calle E, Bayona Cebada A, et al
    Switching to an advanced hybrid closed-loop system in real-world practice improves hypoglycemia awareness and metabolic control in adults with type 1 diabetes, particularly in those with impaired perception of hypoglycemia symptoms.
    Diabetes Res Clin Pract. 2023;199:110627.
    PubMed         Abstract available
    
    
15. GUO S, Huang Y, Liu X, Ma J, et al
    Association of type 1 diabetes mellitus and risk of atrial fibrillation: Systematic review and meta-analysis.
    Diabetes Res Clin Pract. 2023;199:110629.
    PubMed         Abstract available
    
    
16. CHEN HJ, Lee YJ, Huang CC, Yen YC, et al
    The effect of age at onset of type 1 diabetes mellitus on epilepsy vulnerability.
    Diabetes Res Clin Pract. 2023;199:110638.
    PubMed         Abstract available
    
    
17. MICHOU P, Gkiourtzis N, Christoforidis A, Kotanidou EP, et al
    The efficacy of automated insulin delivery systems in children and adolescents with type 1 diabetes Mellitus: A systematic review and meta-analysis of randomized controlled trials.
    Diabetes Res Clin Pract. 2023;199:110678.
    PubMed         Abstract available
    
    

    
    Intern Med

18. SAKANE N, Kato K, Hata S, Nishimura E, et al
    Association of Impaired Awareness of Hypoglycemia with Driving Safety and Hypoglycemia Problem-solving Abilities among Patients with Type 1 Diabetes in Japan: The PR-IAH Study.
    Intern Med. 2023;62:1431-1439.
    PubMed         Abstract available
    
    
19. AOCHI S, Uehara M, Yamamoto M
    IgG4-related Disease Emerging after COVID-19 mRNA Vaccination.
    Intern Med. 2023;62:1547-1551.
    PubMed         Abstract available
    
    
20. UCHINO K, Soga K, Shinohara K, Imai T, et al
    Anti-myelin Oligodendrocyte Glycoprotein Antibody-positive Myelitis after Coronavirus Disease 2019.
    Intern Med. 2023;62:1531-1535.
    PubMed         Abstract available
    
    
21. KOGA Y, Yoshimi S, Harada T, Suzuki S, et al
    Long-term Safety and Efficacy of Benralizumab for Eosinophilic Granulomatosis with Polyangiitis Complicated with Severe Neuropathy.
    Intern Med. 2023;62:1553-1556.
    PubMed         Abstract available
    
    
22. OZAKA S, Kodera T, Tsutsumi K, Fukuda M, et al
    Acute Cholecystitis Associated with Eosinophilic Granulomatosis with Polyangiitis That Responded to Glucocorticoid Therapy.
    Intern Med. 2023;62:1501-1506.
    PubMed         Abstract available
    
    
23. MORIYA K, Saeki K, Nishimura N, Sato S, et al
    Zinc Supplementation and an Improved Quality of Life in Patients with Autoimmune Hepatitis.
    Intern Med. 2023 May 17. doi: 10.2169/internalmedicine.1817.
    PubMed         Abstract available
    
    
24. KAWAKAMI E, Uchida T, Iwamoto N, Hara K, et al
    Anti-melanoma Differentiation-associated Gene 5 Antibody-positive Dermatomyositis Presenting as Refractory Gingivitis at the First Clinical Manifestation: A Case Report.
    Intern Med. 2023 May 17. doi: 10.2169/internalmedicine.1621.
    PubMed         Abstract available
    
    

    
    J Autoimmun

25. ZHANG B, Zhou W, Liu Q, Huang C, et al
    Effects of fecal microbiota transplant on DNA methylation in patients with systemic lupus erythematosus.
    J Autoimmun. 2023 May 11:103047. doi: 10.1016/j.jaut.2023.103047.
    PubMed         Abstract available
    
    
26. XIN Y, Huang C, Zheng M, Zhou W, et al
    Fecal microbiota transplantation in the treatment of systemic lupus erythematosus: What we learnt from the explorative clinical trial.
    J Autoimmun. 2023 May 11:103058. doi: 10.1016/j.jaut.2023.103058.
    PubMed         Abstract available
    
    

    
    J Clin Endocrinol Metab

27. GALDERISI A, Evans-Molina C, Martino M, Caprio S, et al
    Beta cell function and insulin sensitivity in youth with early type 1 diabetes from a two-hour 7-sample OGTT.
    J Clin Endocrinol Metab. 2022 Dec 21:dgac740. doi: 10.1210.
    PubMed         Abstract available
    
    
28. WRIGHT JJ, Johnson DB
    Approach to the Patient With Immune Checkpoint Inhibitor-Associated Endocrine Dysfunction.
    J Clin Endocrinol Metab. 2023;108:1514-1525.
    PubMed         Abstract available
    
    
29. URRUTIA I, Martinez R, Calvo B, Saso-Jimenez L, et al
    Autoimmune Diabetes From Chilhood to Adulthood: The Role of Pancreatic Autoantibodies and Hla-Drb1 Genotype.
    J Clin Endocrinol Metab. 2023 May 19:dgad277. doi: 10.1210.
    PubMed         Abstract available
    
    

    
    J Immunol

30. ZHANG W, Mackay CR, Gershwin ME
    Immunomodulatory Effects of Microbiota-Derived Short-Chain Fatty Acids in Autoimmune Liver Diseases.
    J Immunol. 2023;210:1629-1639.
    PubMed         Abstract available
    
    
31. SINGH SP, Parween F, Edara N, Zhang HH, et al
    Human CCR6+ Th Cells Show Both an Extended Stable Gradient of Th17 Activity and Imprinted Plasticity.
    J Immunol. 2023;210:1700-1716.
    PubMed         Abstract available
    
    
32. BUZZELLI AA, McWilliams IL, Shin B, Bryars MT, et al
    Intrinsic STAT4 Expression Controls Effector CD4 T Cell Migration and Th17 Pathogenicity.
    J Immunol. 2023;210:1667-1676.
    PubMed         Abstract available
    
    
33. GREILACH SA, McIntyre LL, Nguyen QH, Silva J, et al
    Presentation of Human Neural Stem Cell Antigens Drives Regulatory T Cell Induction.
    J Immunol. 2023 Apr 21:ji2200798. doi: 10.4049/jimmunol.2200798.
    PubMed         Abstract available
    
    

    
    J Neuroimmunol

34. GE A, Sun Y, Kiker T, Zhou Y, et al
    A metabolome-wide Mendelian randomization study prioritizes potential causal circulating metabolites for multiple sclerosis.
    J Neuroimmunol. 2023;379:578105.
    PubMed         Abstract available
    
    
35. ABOSEIF A, Toljan K, Mahadeen A, Zeft A, et al
    Pediatric anti-NMDA-receptor autoimmune encephalitis in siblings: Developmental, Electrophysiologic, and Genetic Implications.
    J Neuroimmunol. 2023;379:578107.
    PubMed         Abstract available
    
    
36. XUE Y, Zhang L, Guo R, Shao X, et al
    miR-485 regulates Th17 generation and pathogenesis in experimental autoimmune encephalomyelitis through targeting STAT3.
    J Neuroimmunol. 2023;379:578100.
    PubMed         Abstract available
    
    

    
    J Neurol

37. LIU B, Hu J, Sun C, Qiao K, et al
    Effectiveness and safety of rituximab in autoimmune nodopathy: a single-center cohort study.
    J Neurol. 2023 May 17. doi: 10.1007/s00415-023-11759.
    PubMed         Abstract available
    
    
38. ZANETTA C, Rocca MA, Meani A, Martinelli V, et al
    Correction to: Effectiveness and safety profile of cladribine in an Italian real-life cohort of relapsing-remitting multiple sclerosis patients: a monocentric longitudinal observational study.
    J Neurol. 2023 May 17. doi: 10.1007/s00415-023-11772.
    PubMed        
    
    
39. AZZIMONTI M, Preziosa P, Pagani E, Valsasina P, et al
    Functional and structural brain MRI changes associated with cognitive worsening in multiple sclerosis: a 3-year longitudinal study.
    J Neurol. 2023 May 18. doi: 10.1007/s00415-023-11778.
    PubMed         Abstract available
    
    
40. ROSSI S, Gelsomino F, Rinaldi R, Muccioli L, et al
    Peripheral nervous system adverse events associated with immune checkpoint inhibitors.
    J Neurol. 2023;270:2975-2986.
    PubMed         Abstract available
    
    
41. YIN Z, Qiu Y, Duan A, Fang T, et al
    Different monoclonal antibodies and immunosuppressants administration in patients with neuromyelitis optica spectrum disorder: a Bayesian network meta-analysis.
    J Neurol. 2023;270:2950-2963.
    PubMed         Abstract available
    
    
42. HOLTZER R, Choi J, Motl RW, Foley FW, et al
    Individual reserve in aging and neurological disease.
    J Neurol. 2023;270:3179-3191.
    PubMed         Abstract available
    
    
43. HTET ZM, Tallantyre E
    Optic neuritis and MOGAD.
    J Neurol. 2023;270:3278-3279.
    PubMed        
    
    

    
    Mult Scler

44. ROMAN S
    A journey with no roadmap-The need for validated criteria of the MS prodrome.
    Mult Scler. 2023;29.
    PubMed         Abstract available
    
    
45. ALSHEHRI E, Cohen JA, Ontaneda D, Nakamura K, et al
    The impact of cigarette smoking on cognitive processing speed and brain atrophy in multiple sclerosis.
    Mult Scler. 2023 May 19:13524585231172490. doi: 10.1177/13524585231172490.
    PubMed         Abstract available
    
    
46. VIRUPAKSHAIAH A, Ladakis DC, Nourbakhsh B, Bhargava P, et al
    Several serum lipid metabolites are associated with relapse risk in pediatric-onset multiple sclerosis.
    Mult Scler. 2023 May 18:13524585231171517. doi: 10.1177/13524585231171517.
    PubMed         Abstract available
    
    
47. VALENTINE TR, Kratz AL, Kaplish N, Chervin RD, et al
    Sleep-disordered breathing and neurocognitive function in multiple sclerosis: Differential associations across cognitive domains.
    Mult Scler. 2023 May 17:13524585231169465. doi: 10.1177/13524585231169465.
    PubMed         Abstract available
    
    

    
    Neurologia (Engl Ed)

48. FUERTE-HORTIGON A, Garcia-Campos C, Sanchez-Sanchez V
    Acute inflammatory demyelinating polyneuropathy shortly after administration of intravitreal ranibizumab.
    Neurologia (Engl Ed). 2023;38:309-311.
    PubMed        
    
    

    
    Neurology

49. 
    Randomized Double-Blind Placebo-Controlled Trial of the Corticosteroid-Sparing Effects of Immunoglobulin in Myasthenia Gravis.
    Neurology. 2023 Apr 25:10.1212/WNL.0000000000207433.
    PubMed        
    
    

    
    PLoS One

50. SU K, Jia Z, Wu Y, Sun Y, et al
    A network causal relationship between type-1 diabetes mellitus, 25-hydroxyvitamin D level and systemic lupus erythematosus: Mendelian randomization study.
    PLoS One. 2023;18:e0285915.
    PubMed         Abstract available
    
    
51. AHMAD POUZI NA, Shaharir SS, Mohd Tamil A, Mustafar R, et al
    Validation and the associated factors of the Malay version of systemic lupus erythematosus-specific health-related quality of life questionnaires (SLEQoL and LupusQoL).
    PLoS One. 2023;18:e0285461.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Autoimmune Disorders is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: